Drug Shortage Report for GLYCOPYRROLATE INJECTION USP
Report ID | 245519 |
Drug Identification Number | 02473895 |
Brand name | GLYCOPYRROLATE INJECTION USP |
Common or Proper name | GLYCOPYRROLATE INJECTION USP |
Company Name | STERIMAX INC |
Market Status | MARKETED |
Active Ingredient(s) | GLYCOPYRROLATE |
Strength(s) | 0.4MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAMUSCULAR |
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
Additional packaging sizes | 10 VIALS X 2 ML |
ATC code | A03AB |
ATC description | DRUGS FOR FUNCTIONAL BOWEL DISORDERS |
Reason for shortage | Requirements related to complying with good manufacturing practices. |
Anticipated start date | |
Actual start date | 2024-12-10 |
Estimated end date | 2025-07-04 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2025-04-10 |
Company comments | Contract coverage is in place. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2770 PORTLAND DRIVE OAKVILLE, ONTARIO CANADA L6H 6R4 |
Company contact information | 1-800-881-3550 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v12 | 2025-04-10 | French | Compare |
v11 | 2025-04-10 | English | Compare |
v10 | 2025-03-20 | French | Compare |
v9 | 2025-03-20 | English | Compare |
v8 | 2025-02-27 | French | Compare |
v7 | 2025-02-27 | English | Compare |
v6 | 2025-01-23 | French | Compare |
v5 | 2025-01-23 | English | Compare |
v4 | 2025-01-08 | French | Compare |
v3 | 2025-01-08 | English | Compare |
v2 | 2024-12-12 | French | Compare |
v1 | 2024-12-12 | English | Compare |
Showing 1 to 12 of 12